Alcoholic Hepatitis (AH) – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030
Alcoholic hepatitis (AH) is an acute life and health-threatening disease. The clinical syndrome of jaundice and liver failure in alcohol abusers is typically called “acute alcoholic hepatitis” or “alcoholic hepatitis”, which is the most serious manifestation of the alcoholic liver disease spectrum. The clinical presentation of AH is heterogeneous and ranges from mild to severe and AH is often associated with the systemic inflammatory response syndrome (SIRS) and moderate fever, with or without infection. Up to thirty-five percent of all heavy drinkers will have signs of alcoholic steatohepatitis in liver biopsies even though they may never develop the clinical syndrome. There are no standards or international consensus on the diagnostic criteria for AH. The combination of normal to mildly elevated aminotransferases, a total serum bilirubin level of more than 80 μmol per liter, an elevated INR, and neutrophilia in with a history of heavy alcohol use is suggestive of AH. The competitive ...